The intelligent transcutaneous jaundice device and intelligent ovulation detection device products have won the Good Design Award in the United States!

E3A Healthcare participates at the World Young Scientist’s Summit in Wenzhou, China

E3A Healthcare participated in the 5th China International Import Expo and Debuted its new Jaundice Monitor product line on China Central Television

The global finals of the 2022 Singapore SLINGSHOT International Innovation Competition were successfully concluded on October 27th at Singapore Science and Technology Innovation Week.

E3A Healthcare CMO Harry Chen attended the 2022 Global Digital Economy Innovation Conference and won the runner-up in the final of the Innovation Competition

E3A Healthcare has been successfully selected for the Hong Kong Science and Technology Park Innovation and Cultivation Program （HKSTP INCUBATION）

Dr. Li Shihao, CEO of E3A Healthcare, gave an exclusive interview with CGTN on the future prospects of Hong Kong after the election of the new Chief Executive of Hong Kong.

E3A Healthcare was invited to speak at the 2022 China World Youth Summit Spring Summit

E3A Healthcare has officially launched a new round of recruitment. We welcome more ambitious young people to join us and grow together!

The two product lines of E3A have been officially approved by the FDA and CFDA, and a new round of financing has been officially launched in December 2021.

The E3A Healthcare - Intelligent Maternal and Child Home Medical Device Project stood out in the 2021 Shenzhen-Guangdong-Hong Kong-Macao-Taiwan Youth Innovation and Entrepreneurship Competition and won the Bronze Award in the Enterprise Group.

E3A Healthcare won the third prize in the 2021 Shenzhen Dream Chasing Cup College Student Innovation and Entrepreneurship Competition.

E3A Healthcare has been awarded funding of S $250000 from the Singapore Enterprise Development Authority (ESG) project.

Congratulations to Dr. Li Shihao, founder of E3A Healthcare!